MRD Monitoring in Acute Lymphoblastic Leukemia
0 Visningar
• 06/15/23
0
0
Bädda in
administrator
Prenumeranter
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna